Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression
Open Access
- 15 September 2009
- journal article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 13 (04), 411-420
- https://doi.org/10.1017/s1461145709990587
Abstract
Accumulating evidence suggests dysfunction of the gamma-aminobutyric acid (GABA) system in major depressive disorder (MDD). Neuroimaging studies consistently report reductions of cortical GABA in depressed patients. Our post-mortem analyses demonstrate a reduction in the density and size of GABAergic interneurons in the dorsolateral prefrontal cortex (DLPFC) in MDD. The goal of this study was to test whether the level of glutamic acid decarboxylase (GAD), the GABA synthesizing enzyme, will also be reduced in the same cortical region in MDD. Levels of GAD-65 and GAD-67 proteins were investigated by Western blotting in samples from the DLPFC (BA 9) in 13 medication-free subjects with MDD, and 13 psychiatrically healthy controls. The overall amount of GAD-67 was significantly reduced (−34%) in depressed subjects compared to matched controls. Since recent neuroimaging studies have demonstrated that antidepressants modulate GABA levels, additional experiments were performed to examine the levels of GAD in eight depressed subjects treated with antidepressant medications. Levels of GAD-67 were unchanged in these depressed subjects compared to their respective controls (n=8). The overall amounts of GAD-65 were similar in depressed subjects compared to matched controls, regardless of antidepressant medication. Reduced levels of GAD-67, which is localized to somata of GABA neurons, further support our observation of a decreased density of GABAergic neurons in the PFC in depression. It is likely that a decrease in GAD-67 accounts for the reduction in GABA levels revealed by neuroimaging studies. Moreover, our data support previous neuroimaging observations that antidepressant medication normalizes GABA deficits in depression.Keywords
This publication has 44 references indexed in Scilit:
- Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicideBrain Research, 2006
- Antidepressant‐like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodentsBritish Journal of Pharmacology, 2006
- GABAergic Neurons Immunoreactive for Calcium Binding Proteins are Reduced in the Prefrontal Cortex in Major DepressionNeuropsychopharmacology, 2006
- GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellumSchizophrenia Research, 2005
- Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAAReceptor Subunits in Frontal Cortical Brain RegionJournal of Neuroscience, 2004
- Mice Lacking the 65 kDa Isoform of Glutamic Acid Decarboxylase (GAD65) Maintain Normal Levels of GAD67 and GABA in Their Brains but Are Susceptible to SeizuresBiochemical and Biophysical Research Communications, 1996
- Cytoarchitectonic Definition of Prefrontal Areas in the Normal Human Cortex: I. Remapping of Areas 9 and 46 using Quantitative CriteriaCerebral Cortex, 1995
- Two Forms of the γ‐Aminobutyric Acid Synthetic Enzyme Glutamate Decarboxylase Have Distinct Intraneuronal Distributions and Cofactor InteractionsJournal of Neurochemistry, 1991
- Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shockJournal of Neural Transmission, 1983
- SUSTAINED DRUG‐INDUCED ELEVATION OF BRAIN GABA IN THE RAT1Journal of Neurochemistry, 1973